Latest Revenue Model News

Acusensus Limited reported a robust FY25 with 20% revenue growth and a significant 84% jump in total contract value, setting the stage for an ambitious FY26 forecast of up to 41% revenue increase.

Acrow Limited reports a record FY25 with sales up 23%, driven by an 83% jump in its Industrial Access division, now half of group revenue. Despite soft formwork markets, strategic acquisitions and growth initiatives underpin a confident outlook.

Infomedia Ltd reported solid FY25 results with revenue up 4% to $146.5 million and net profit rising 32%, driven by key product growth and a strategic AI acquisition. The company also recommended shareholder approval of a premium takeover offer from TPG Capital.

Dalrymple Bay Infrastructure Limited (DBI) reports a strong first half of 2025 with increased funds from operations and distributions, underpinned by a stable, inflation-linked revenue model and significant capital investment in terminal maintenance and expansion.

Nuix Limited reported an 8% rise in Annualised Contract Value for FY25, driven by a remarkable 132% growth in its Nuix Neo platform. Despite flat revenue, the company achieved a 24.5% increase in Cash EBITDA and outlined a confident outlook for FY26.

Nuix Limited reported a slight revenue increase to $221.5 million for FY25 but swung to a net loss of $9.2 million, weighed down by rising legal fees and restructuring costs. The company’s AI-driven Nuix Neo platform showed strong contract growth, while cash EBITDA improved significantly.

Cuscal Limited has reported a strong FY25 performance exceeding its Prospectus forecasts and announced a $75 million cash acquisition of Indue Limited, aiming to create a more resilient and competitive payments business.

Swift Networks has renewed a $2.4 million contract to provide continuous technical support and entertainment services across three Chevron sites, reinforcing its foothold in the Oil and Gas sector.

Objective Corporation reported solid FY2025 results with 5% revenue growth and a 15% jump in Annualised Recurring Revenue, underpinned by significant R&D investment and a strong subscription model.

Objective Corporation Limited reported a solid 5% revenue increase to $123.5 million and a 13% rise in net profit after tax to $35.44 million for FY2025, alongside a strategic acquisition that broadens its e-planning software portfolio.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.

Argent BioPharma has signed a binding term sheet to acquire key assets from AusCann Group Holdings, significantly expanding its clinical pipeline, intellectual property, and European manufacturing and distribution capabilities ahead of a planned US stock exchange listing.